Literature DB >> 17097374

Aggressive histiocytic disorders that can involve the skin.

Brenda Newman1, Weimin Hu, Kelly Nigro, Anita C Gilliam.   

Abstract

Histiocytoses are a heterogeneous group of disorders that are characterized by the proliferation and accumulation of reactive or neoplastic histiocytes. Three classes of histiocytoses have been defined: class I, Langerhans cell disease; class II, non-Langerhans cell histiocytic disease without features of malignancy; and class III, malignant histiocytic disorders. Although the disorders in classes I and II usually have a benign appearance on histology and are commonly non-aggressive and self-healing, some can cause debilitating or even fatal outcomes. Such cases beg the question: what stimulates aggressive behavior of a classically benign disease? New molecular information may now provide insight into the driving force behind many of the aggressive histiocytoses. In this article, we review Langerhans cell disease and seven aggressive histiocytoses that can involve skin, discuss histologic features that may forecast a poor prognosis, and discuss the molecular findings that help to explain the pathophysiology of these aggressive histiocytic disorders.

Entities:  

Mesh:

Year:  2006        PMID: 17097374     DOI: 10.1016/j.jaad.2006.06.010

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  12 in total

1.  Malignant histiocytosis of the skin: a case report and review of the literature.

Authors:  Nicole M Demers; Jeremy Bowers; Christina Appin; Michael B Morgan
Journal:  J Dermatol Case Rep       Date:  2009-04-05

2.  An Unusual Juvenile Xanthogranulomaon a Finger MCP Joint.

Authors:  Sang Hee Cha; Sang Hyun Cho; Jeong Deuk Lee
Journal:  Ann Dermatol       Date:  2008-12-31       Impact factor: 1.444

Review 3.  Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract.

Authors:  Dagmar Simon; Andrew Wardlaw; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2010-04-14       Impact factor: 10.793

Review 4.  Non-sclerotic bone involvement in Erdheim-Chester: PET/CT and MRI findings in a 15-year-old boy.

Authors:  Theresa V White; Nicholas C Silvester; Hansel J Otero
Journal:  Pediatr Radiol       Date:  2016-03-30

5.  [Cutaneous Rosai-Dorfman syndrome. Successful therapy with intrralesional corticosteroids].

Authors:  S Vandersee; H-J Röwert-Huber; S Wöhner; C Loddenkemper; M Beyer; D Humme
Journal:  Hautarzt       Date:  2014-08       Impact factor: 0.751

6.  Indeterminate cell histiocytosis in association with acute myeloid leukemia.

Authors:  Filipa Ventura; Teresa Pereira; Maria da Luz Duarte; Herlander Marques; Fernando Pardal; Celeste Brito
Journal:  Dermatol Res Pract       Date:  2010-06-21

7.  BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate.

Authors:  Sara V Bates; Ashwini Lakshmanan; Adam L Green; Jefferson Terry; Gayane Badalian-Very; Barrett J Rollins; Patricia Fleck; Muhammad Aslam; Barbara A Degar
Journal:  AJP Rep       Date:  2013-03-18

8.  Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years.

Authors:  Samir Dalia; Michael Jaglal; Paul Chervenick; Hernani Cualing; Lubomir Sokol
Journal:  Cancers (Basel)       Date:  2014-11-14       Impact factor: 6.639

9.  Purely cutaneous Langerhans cell histiocytosis presenting as an ulcer on the chin in an elderly man successfully treated with thalidomide.

Authors:  Radhakrishnan Subramaniyan; Rajagopal Ramachandran; Gnanasekaran Rajangam; Navya Donaparthi
Journal:  Indian Dermatol Online J       Date:  2015 Nov-Dec

10.  Combined Cutaneous Rosai-Dorfman Disease and Localized Cutaneous Langerhans Cell Histiocytosis Within a Single Subcutaneous Nodule.

Authors:  Brandon R Litzner; Antonio Subtil; Claudia I Vidal
Journal:  Am J Dermatopathol       Date:  2015-12       Impact factor: 1.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.